Amdocs Limited (DOX) Stock Price & How to Invest

Amdocs Limited builds and operates the software that communications and media companies use to sell, bill and support their services. Its products sit in what the industry calls BSS and OSS: customer care, product catalogs, charging and billing, and order management on the commercial side, plus network orchestration, provisioning and service assurance on the operations side. Most of the revenue no longer comes from selling licenses. It comes from managed services, where Amdocs staff run those systems inside the carrier's own environment under multi-year contracts, a line that reached a record $791 million, or 67% of sales, in the June 2026 quarter. The rest is systems integration and cloud migration, the slow work of lifting decades-old on-premise stacks onto AWS, Azure and Google Cloud. Customers include AT&T, T-Mobile US, Vodafone, Telefonica's Vivo, Comcast, Lumen, Sunrise and Liberty Latin America. The company was founded in Israel in 1982, is incorporated in Guernsey, runs its main operating centers in Ra'anana and in Chesterfield, Missouri, employs roughly 30,000 people, and closes its fiscal year on September 30.

The investment picture in August 2026 is a valuation argument rather than a growth story. Trailing revenue is about $4.65 billion against a market capitalization near $6.08 billion, so the entire company trades at roughly 1.3 times sales and around 7 times consensus non-GAAP earnings, inside a 52-week range of $49.74 to $88.61. Revenue rose 2.7% year over year last quarter and management guides fiscal 2026 to 3.2% to 4.0% reported growth, slow enough that the market has stopped paying a software multiple for it. What the business still does well is convert. Guidance calls for $710 million to $730 million of free cash flow excluding restructuring payments, more than 11% of the current market value, which funds a $2.28 annual dividend and $143 million of repurchases in the June quarter alone. The bear case is that much of that revenue is human effort billed by the hour, and that agentic AI lets carriers demand the same outcome for less. The bull case is that sitting inside a carrier's billing stack for twenty years is the ideal place from which to sell the automation layer, which is what the new aOS platform and the ten-year Liberty Latin America contract are meant to prove.

Customer concentration is the structural risk: AT&T has accounted for roughly a quarter of revenue in recent years and T-Mobile US is the next largest, so one carrier's budget decision moves the whole income statement, and management has already said it expects T-Mobile revenue to decline in fiscal 2026 as non-recurring work winds down. The second risk is the one the market is currently pricing, that agentic AI turns a large pool of billable human delivery into something customers expect to pay far less for, which would show up as repricing at contract renewal rather than as a sudden revenue drop. Growth is already slow at 2.7% in the latest quarter, which leaves almost no cushion if a large renewal comes in smaller. Telecom consolidation cuts both ways, since a merger can create a large integration project or eliminate a customer entirely. Currency swings and the concentration of engineering staff in Israel add operational exposure that a purely US-domiciled peer would not carry, and the $106 million restructuring charge is a reminder that reshaping the cost base is neither free nor finished.

4 analysts publish price targets on DOX, averaging $81.21 against a $57.28 price as of August 2026, or +41.8%. The published targets run from $70.84 to $105.00, a moderate spread, and the ratings split 3 buy, 3 hold, 0 sell. Over the last six months there have been 0 raises and 1 cut among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full DOX forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Amdocs Limited. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Managed services turned a project vendor into an annuity. Managed services hit a record $791 million in the June 2026 quarter, 67% of total revenue, and the 12-month backlog stood at about $4.26 billion, up 2.7% year over year. The most optimistic published target, $105.00, assumes this works close to its best case.

The case against. Customer concentration is the structural risk: AT&T has accounted for roughly a quarter of revenue in recent years and T-Mobile US is the next largest, so one carrier's budget decision moves the whole income statement, and management has already said it expects T-Mobile revenue to decline in fiscal 2026 as non-recurring work winds down. The most pessimistic target, $70.84, is roughly what DOX is worth if this bites instead.

Read the full bull and bear case on DOX, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Amdocs Limited's investor relations page or your broker.

• Revenue (TTM): ~$4.65 billion
• Revenue (Q3 FY2026): ~$1.175 billion, up ~2.7% year over year
• Non-GAAP diluted EPS (Q3 FY2026): ~$1.84
• 12-month backlog: ~$4.26 billion, up ~2.7% year over year
• Free cash flow (FY2026 guidance): ~$710 million to $730 million, excluding restructuring payments
• Market cap and dividend: ~$6.08 billion; ~$2.28 annual dividend, ~4.0% yield

At about $57 a share, DOX trades near 13.6 times trailing GAAP earnings and roughly 7 times consensus non-GAAP earnings, a multiple usually reserved for businesses the market expects to shrink. Much of the gap between those two figures is the $106 million restructuring charge taken in the June quarter, which weighed on GAAP results without changing the cash flow guidance. Whether the discount is deserved depends less on any single quarter's revenue than on whether the 12-month backlog keeps renewing at current margins.

Other names that sit close to DOX: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get DOX exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so DOX sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where DOX fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

Amdocs is a slow-growing, cash-generative piece of telecom infrastructure priced as though it will shrink, and the thesis turns on one question: whether agentic AI compresses the services revenue it bills for, or lets it deliver the same contracts at a wider margin.

Whether DOX is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is DOX a buy or a sell?, and where the stock could go from here in the DOX stock forecast.

For income investors, whether DOX pays a dividend and how the payout looks is covered in does DOX pay a dividend? And to weigh DOX against a peer, read the full side-by-side comparisons: DOX vs NOK and DOX vs ACN.